These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Use of clotrimazole/betamethasone diproprionate by family physicians. Shaffer MP, Feldman SR, Fleischer AB. Fam Med; 2000 Sep; 32(8):561-5. PubMed ID: 11002867 [Abstract] [Full Text] [Related]
3. Nondermatologists are more likely than dermatologists to prescribe antifungal/corticosteroid products: an analysis of office visits for cutaneous fungal infections, 1990-1994. Smith ES, Fleischer AB, Feldman SR. J Am Acad Dermatol; 1998 Jul; 39(1):43-7. PubMed ID: 9674396 [Abstract] [Full Text] [Related]
4. Persistent and recurrent tinea corporis in children treated with combination antifungal/ corticosteroid agents. Alston SJ, Cohen BA, Braun M. Pediatrics; 2003 Jan; 111(1):201-3. PubMed ID: 12509578 [Abstract] [Full Text] [Related]
5. Pediatricians who prescribe clotrimazole-betamethasone diproprionate (Lotrisone) often utilize it in inappropriate settings regardless of their knowledge of the drug's potency. Railan D, Wilson JK, Feldman SR, Fleischer AB. Dermatol Online J; 2002 Oct; 8(2):3. PubMed ID: 12546758 [Abstract] [Full Text] [Related]
6. Striae and persistent tinea corporis related to prolonged use of betamethasone dipropionate 0.05% cream/clotrimazole 1% cream (Lotrisone cream). Barkey WF. J Am Acad Dermatol; 1987 Sep; 17(3):518-9. PubMed ID: 3655035 [No Abstract] [Full Text] [Related]
7. Double-blind comparison of naftifine cream and clotrimazole/betamethasone dipropionate cream in the treatment of tinea pedis. Smith EB, Breneman DL, Griffith RF, Hebert AA, Hickman JG, Maloney JM, Millikan LE, Sulica VI, Dromgoole SH, Sefton J. J Am Acad Dermatol; 1992 Jan; 26(1):125-7. PubMed ID: 1732321 [No Abstract] [Full Text] [Related]
8. Current Trends in the Use of Two Combination Antifungal/Corticosteroid Creams. Wheat CM, Bickley RJ, Hsueh YH, Cohen BA. J Pediatr; 2017 Jul; 186():192-195.e1. PubMed ID: 28438376 [Abstract] [Full Text] [Related]
9. Exacerbation of tinea corporis during treatment with 1% clotrimazole/0.05% betamethasone diproprionate (Lotrisone). Reynolds RD, Boiko S, Lucky AW. Am J Dis Child; 1991 Nov; 145(11):1224-5. PubMed ID: 1951207 [No Abstract] [Full Text] [Related]
10. Prescription of high-potency corticosteroid agents and clotrimazole-betamethasone dipropionate by pediatricians. Fleischer AB, Feldman SR. Clin Ther; 1999 Oct; 21(10):1725-31. PubMed ID: 10566568 [Abstract] [Full Text] [Related]
12. Topical treatment of common superficial tinea infections. Weinstein A, Berman B. Am Fam Physician; 2002 May 15; 65(10):2095-102. PubMed ID: 12046779 [Abstract] [Full Text] [Related]
14. A cost analysis of topical drug regimens for dermatophyte infections. Chren MM, Landefeld CS. JAMA; 1994 Dec 28; 272(24):1922-5. PubMed ID: 7990244 [Abstract] [Full Text] [Related]
15. The continued inappropriate use and overuse of combination topical clotrimazole-betamethasone. Flint ND, Rhoads JLW, Carlisle R, Ferrel M, Hopkins ZH, Secrest AM. Dermatol Online J; 2021 Aug 15; 27(8):. PubMed ID: 34755955 [Abstract] [Full Text] [Related]
18. An overview of topical antifungal therapy in dermatomycoses. A North American perspective. Gupta AK, Einarson TR, Summerbell RC, Shear NH. Drugs; 1998 May 15; 55(5):645-74. PubMed ID: 9585862 [Abstract] [Full Text] [Related]